Jamie Christensen, EVP, Chief Scientific Officer at Mirati Therapeutics, Inc. (MRTX), sold 2,884 shares at $147.72 ($426K) on 2022-01-04, disclosed to the SEC on 2022-01-06.
Open-market sale of $426k MRTX by EVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.72 | 1,442 | $213K | 50.0% |
| 2 | $147.72 | 1,442 | $213K | 50.0% |
| Total | $147.72 avg | 2,884 | $426K | 100% |
| Filing → |
| MRTX | SELL | 2023-12-19 | $275K | — | Filing → |
| MRTX | SELL | 2023-09-12 | $170K | — | Filing → |
| MRTX | SELL | 2023-05-24 | $28K | — | Filing → |